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Increasing return-to-work among people on
sick leave due to common mental
disorders: design of a cluster-randomized
controlled trial of a problem-solving
intervention versus care-as-usual
conducted in the Swedish primary health
care system (PROSA)
Elisabeth Björk Brämberg1,2,3* , Kristina Holmgren3,4, Ute Bültmann5, Hanna Gyllensten6,7, Jan Hagberg1,
Lars Sandman8 and Gunnar Bergström1,9
Abstract
Background: Common mental disorders affect about one-third of the European working-age population and are
one of the leading causes of sick leave in Sweden and other OECD countries. Besides the individual suffering, the
costs for society are high. This paper describes the design of a study to evaluate a work-related, problem-solving
intervention provided at primary health care centers for employees on sick leave due to common mental disorders.
Methods: The study has a two-armed cluster randomized design in which the participating rehabilitation
coordinators are randomized into delivering the intervention or providing care-as-usual. Employees on sick leave
due to common mental disorders will be recruited by an independent research assistant. The intervention aims to
improve the employee’s return-to-work process by identifying problems perceived as hindering return-to-work and
finding solutions. The rehabilitation coordinator facilitates a participatory approach, in which the employee and the
employer together identify obstacles and solutions in relation to the work situation. The primary outcome is total
number of sick leave days during the 18-month follow-up after inclusion. A long-term follow-up at 36 months is
planned. Secondary outcomes are short-term sick leave (min. 2 weeks and max. 12 weeks), psychological
symptoms, work ability, presenteeism and health related quality of life assessed at baseline, 6 and 12-month
follow-up. Intervention fidelity, reach, dose delivered and dose received will be examined in a process evaluation. An
economic evaluation will put health-related quality of life and sick leave in relation to costs from the perspectives of
society and health care services. A parallel ethical evaluation will focus on the interventions consequences for patient
autonomy, privacy, equality, fairness and professional ethos and integrity.
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Discussion: The study is a pragmatic trial which will include analyses of the intervention’s effectiveness, and a process
evaluation in primary health care settings. Methodological strengths and challenges are discussed, such as the risk of
selection bias, contamination and detection bias. If the intervention shows promising results for return-to-work, the
prospects are good for implementing the intervention in routine primary health care.
Trial registration: ClinicalTrials.gov Identifier: NCT03346395 Registered January, 12 2018.
Keywords: Common mental disorders, Adjustment disorders, Anxiety disorders, Depression, Cluster-randomized trial,
Problem solving skills, Return to work, Sick leave, Economic evaluation, Ethical evaluation
Background
It is estimated that common mental disorders (CMDs), i.e.
mild to moderate depression, anxiety, adjustment and
stress-related disorders affect about one-third of the
European working-age population. In Sweden, after a
reduction in sickness absence due to CMDs between 2005
and 2010, sickness absence started to increase again in
2011. At present, CMDs are the most common cause of
sick leave in Sweden. In January 2016, CMDs were the
cause of about 45% of all sick leave among women and
32% of all sick leave among men [1]. Besides the indi-
vidual suffering, with its negative impact on the individ-
ual’s well-being, financial circumstances, social network
and risk of stigmatization, the cost for society in terms of
health care, sick leave and productivity loss for employers
is high. In 2013, the total costs for mental health in
Sweden, including sick leave, amounted to some SEK 65
billion (approx. EUR 6 billion) [2].
The first choice of clinical treatment for CMDs is psy-
chological treatment, primarily cognitive behavioral ther-
apy and/or medication [3]. These treatments have positive
effects on symptom reduction and improved function-
ing, yet symptom reduction is not accompanied by in-
creased return-to-work (RTW) [4, 5]. Previous research
shows that, to increase RTW among persons on sick leave
due to CMDs, work place interventions which include co-
operation between the person on sick leave, his/her em-
ployer, the health care services, the social insurance agency
and the occupational health services are needed [6–8].
Cooperation between the stakeholders (i.e. health care ser-
vices, employers, social insurance agency, and occupational
health services) is a prerequisite for reducing sick leave and
increasing RTW. However, a major problem is the lack
of cooperation between these stakeholders. Moreover, pri-
mary health care often fails to focus on RTW and work-
place related interventions [9, 10].
In line with previous research, we found that the first
concern of primary health care professionals is patients’
psychological and physical well-being; the process of RTW
is often of secondary importance [10]. On the basis of pre-
vious evaluations of an evidence-based intervention (i.e. in-
terventions based on problem-solving therapy), we know
that this type of intervention has promising effects on sick
leave among persons with CMDs [7, 11]. However, the
Swedish primary health care system has a limited history
of workplace interventions which include cooperation with
the workplace. This represents a new challenge for primary
health care.
Workplace interventions are defined as interventions
which target or involve the workplace, work organization,
work conditions or work environment and/or occupational
(case) management strategies with active stakeholder in-
volvement [12]. Evidence of effective workplace RTW inter-
ventions for people with CMDs is limited and the studies
vary with respect to inclusion criteria (cf. [13, 14]). How-
ever, it has been shown that interventions with a work-
place component, including vocational counseling, are
more likely to succeed in increasing RTW than interven-
tions that do not include such a component (cf. [6, 15, 16]).
The British National Institute of Clinical Excellence’s guide-
line on long-term sickness absence and work incapacity
identifies early, multidisciplinary and workplace-focused in-
terventions as those most likely to give positive results [17].
In a recent review, no significant benefits were found
for coordinated RTW programs [13]. However, only two of
the review’s 14 studies reported outcomes for populations
with CMDs and these were conducted outside Sweden, in
coutries with other social security systems than the Swedish
system [13]. A key element of workplace interventions is
cooperation between the employer, the person on sick leave
and health care professionals. The cooperation between
these actors in the RTW process has been described as
challenging because each actor represents different per-
spectives and interests [9].
Previous studies have shown that problem-solving skills
and work-focused cognitive behavioral therapy are more
effective than guideline-based interventions in reducing
the time to first RTW among employees on sick-leave for
CMDs. Guideline-based interventions did not reduce time
to return to full-time work [7, 14, 18, 19]. In a web-based
intervention which included problem-solving skills and
relapse prevention, a significantly faster first RTW was
found for the intervention group. No significant dif-
ferences were found for time until full RTW or in reduced
total number of days on sick leave at the 12-month
follow-up [20]. A review of interventions to improve time
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to first RTW among people with depression gave moder-
ately good evidence that workplace interventions in com-
bination with clinical interventions reduced the number
of days on sick leave significantly more than clinical in-
terventions alone [21]. Similar results were found by an
updated review which evaluated the effects of workplace
interventions among workers with mental health prob-
lems. The results demonstrated a significantly better re-
duction in time to first RTW than care-as-usual [15]. A
cluster-randomized controlled trial in the Netherlands dem-
onstrated the 12-month effectiveness of a problem-solving
intervention for reducing recurrent sick leave among
workers with CMDs. The intervention group had a lower
incidence of recurrent sick leave than the control group
which received care-as-usual [11]. Economic evaluations
of such interventions have shown varying results, from
reduced to increased health care costs [22–25].
To date, only a limited number of studies have evalu-
ated the effectiveness of interventions to improve RTW
in a primary health care population [6, 7, 15]. There is
thus a need for more RTW research in the primary health
care context. Previous studies of problem-solving inter-
ventions have been conducted in countries with work en-
vironments, sickness absence and social security systems
which differ from those in Sweden [6, 7, 11, 15]. The
(financial) implications of employers to cooperating with
the health care services may also differ in the Swedish
system. These differences may in turn affect the effective
components of the intervention and influence the way the
intervention works and how likely it is to result in suc-
cessful outcomes. Most studies have primarily focused on
time to first RTW [6, 15] or recurrent sick leave after
RTW [7]. The effect evaluations have been conducted
in occupational health service settings, have had rela-
tively small sample sizes and lacked a long-term follow
up (i.e. ˃ 12 months) [8]. In Sweden, the primary health
care service is responsible for treatment, issuing sickness
certificates and assessing the individual’s work capacity.
Hence, it is important to adapt the problem-solving inter-
vention to the primary health care setting and evaluate the
intervention in that context.
This paper presents the design of a study, which
evaluates a work-related problem-solving intervention
provided at primary health care centers (PCCs) for
employees on sick leave due to common mental dis-
orders. We hypothesize that participants who have
undergone the problem-solving intervention will have
fewer total sick leave days and fewer recurrent sick
leave periods after RTW than the participants who
receive care-as-usual (CAU). In addition, a process
evaluation of the intervention and its association with
the effects on sick leave, an economic evaluation and
an evaluation of the ethical issues raised by the inter-
vention will be conducted.
Methods
The CONSORT statement and the extension for random-
ized controlled trials were used to describe the study design
[26, 27].
Study design and setting
The study is designed as a two-armed cluster-randomized
controlled trial of a problem-solving intervention to re-
duce sick leave compared with CAU (Fig. 1). In Sweden,
persons who cannot work due to disease or injury are
entitled to benefits from a mainly tax-funded social insur-
ance system. Individuals who are gainfully employed re-
ceive economic compensation from their employer for the
first 14 days (except for one qualification day). Thereafter,
the Social Insurance Agency grants the benefits. A sick-
ness certificate issued by a physician in the primary health
care system is needed from day 8. In an effort to improve
RTW, Swedish county councils have introduced rehabili-
tation coordinators (RCs) whose role is to coordinate the
RTW of persons who are on sick leave for whatever rea-
son. RCs are commonly registered nurses, physiothera-
pists, occupational therapists or social workers.
The study will be conducted in the primary health care
service of the Västra Götaland region of Sweden. This
service comprises some 200 publicly-funded PCCs which
provide health care for 1.6 million people of all ages.
Around 180 (90%) of the 200 PCCs have an on-site RC.
Recruitment of rehabilitation coordinators
RCs were recruited from PCCs in the Västra Götaland
region. Information about the study was sent to managers
in the region by the first author (EBB) and was given at
meetings with PCC managers and RCs. Only RCs not par-
ticipating in other ongoing interventional studies at the
time of inclusion were invited to participate. RCs were
also excluded if they had an upcoming leave of absence
(for example pregnancy leave, a sabbatical) or if they were
leaving the PCC or retiring. About 80 coordinators re-
ceived an invitation. Written information about the study
was provided as well as a registration form and informed
consent. Written informed consent was obtained from all
RCs. The recruitment process resulted in 19 RCs covering
24 PCCs.
Recruitment of participants
To be eligible for the study an employee must be on sick
leave due to CMDs and must have been diagnosed by a
physician at a PCC which is participating in the study.
The current sick leave period should last a minimum of
2 weeks and a maximum of 12 weeks. Employees on sick
leave will be recruited by a research assistant who screens
medical records for inclusion and exclusion criteria. The
research assistant will be blinded to group assignment.
Employees who meet the inclusion criteria will be invited
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to join the study by the research assistant by email.
Eligible employees will receive written information about
the study. Those employees willing to participate must




Eligible participants can be included if they meet the
following criteria:
 Employed women and men aged 18–59 years
 On sick leave (i.e. a minimum of 2 weeks and a
maximum of 12 weeks) with mild to moderate
depression, anxiety or adjustment disorder (F 32, F 41,
F 43) as the primary reason for sick leave, diagnosed
by a physician according to the Swedish version of
international statistical classification of diseases and
related health problems - tenth revision
 Physician works at a PCC in the Västra Götaland
region
 Accept the employer’s involvement
 Understand written and spoken Swedish.
All eligible participants who meet the criteria and con-
sent to participation will be included.
Exclusion criteria
Employees with severe depression; other severe mental
disorders (i.e. psychotic or bipolar disorders or who have
been referred to a psychiatrist); pregnancy; somatic com-
plaints or disorders that affect work ability; those unable
to read, write and understand Swedish will be excluded.
Intervention
Training of rehabilitation coordinators in the intervention
group
The RCs will take part in a two-day training course
about the problem-solving intervention [28]. The train-
ing is provided by a licensed psychologist with extensive
experience of problem-solving therapy and of supervis-
ing primary health care professionals. The RCs will
complete a questionnaire about the quality of the train-
ing course and their problem-solving skills before and
after the course, as a part of the process evaluation. The
RCs will have support from a manual and three work
sheets developed by the research group, all based on
Fig. 1 Flowchart and overview of the trial
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research into CMDs, the problem-solving intervention
and the coordinator function. During the intervention
period the RCs will receive supervision and feedback
from the project leader whenever needed.
The problem-solving intervention
The intervention focuses on the individual and the in-
volvement of the workplace [11, 29] in addition to CAU
[3]. The added value on top of CAU is the intervention’s
problem-solving process and the coordination by the RC
between the employee on sick leave, his/her employer
and the health care professionals.
Communication between the employee, the RC and
the employer is needed for making an inventory of prob-
lems, opportunities and identifying the help needed to
solve the problems [11]. The present intervention is a
modified version of the Dutch sharp-at-work intervention
[29] which aimed to prevent recurrence of sick leave
among employees with CMDs who had returned to work.
The Dutch target group differed from the target group
of the present study, i.e. persons on sick leave. The new,
adapted intervention is a five-step problem-solving process
which aims to identify and find possible solutions to prob-
lems perceived as obstructing the RTW process (Fig. 2). A
meeting with the person on sick leave, his/her employer
and the RC is included in the process, as previous research
has stressed the importance of communication between
the different stakeholders [30]. The intervention comprises
the following five steps:
1. Making an inventory of problems and/or
opportunities related to RTW; a collaborative
approach involving employee and RC; employer and
RC.
2. Brainstorming about solutions, involving employee
and RC.
3. Writing down solutions, identifying the support
needed to implement them and assessing their
applicability, involving employee and RC.
4. A meeting with the person on sick leave, the
employer and the RC to discuss solutions and make
an action plan, involving employee, RC and
employer.
5. Evaluation of the action plan and implementation of
solutions, involving employee and RC.
The work-focused problem-solving intervention starts
with the RC interviewing the employee who is on sick
leave. The RC facilitates the employee’s participation in
his/her RTW-process by supporting and encouraging
the employee to take active part in brainstorming and
prioritizing obstacles and possible solutions for RTW.
The first consultation between the employee and the RC
lasts about 45 min and is summarized in the form of a
preliminary list of identified problems and possible solu-
tions. Thereafter the RC interviews the employer by tele-
phone about problem orientation, e.g. how aware the
employer is of the employee’s health problems; how
these problems are apparent in the workplace; the em-
ployer’s understanding of the causes of the illness. This
takes approximately 15 min. The next step is a meeting
of 45–60 min between the employee, the employer and
the RC. In the problem-solving process, the RC facili-
tates a dialogue between the employee and the employer;
thus the employee and employer are responsible for
identifying obstacles and facilitators related to RTW. They
also identify and prioritize solutions and make an action
plan. The action plan also addresses relapse prevention.
The RC evaluates the action plan with the employee.
Care as usual (CAU)
The RCs in the control condition will continue to deliver
CAU during the study period. CAU may include strat-
egies for the RTW process and may involve the em-
ployer. However, the strategies used by the RCs to date
are not structured in the same way as in the intervention
condition, and do not follow an explicitly stated guid-
ance by problem-solving therapy.
CAU involves cognitive behavioral therapy or medical
treatment, or a combination of both [3], as well as the co-
ordination of RTW (meeting with a RC). We will make no
Fig. 2 Overview of the problem solving intervention
Björk Brämberg et al. BMC Public Health  (2018) 18:889 Page 5 of 11
specific attempts to ensure that the physicians follow the
guidelines for the treatment of CMDs [3]. The partici-
pants, their physicians and, if relevant, their psychologists,
will not receive any information from the project group
about the problem-solving intervention.
Measurements and procedure
Data will be collected by questionnaires, text messages
and the use of registers. Register data will be collected
from the Micro Data for the Analysis of Social Insurance
register (MiDAS) from the Social Insurance Agency, the
Västra Götaland region’s Vega register which is the pa-
tient register for Region Västra Götaland, and the Longi-
tudinal Integration Database for Health Insurance and
Labor Market Studies (LISA), administrated by Statistics
Sweden. Web-based questionnaires will be administered
at baseline and after 6 and 12 months. Text messages will
also be sent to the employees every fourth week over a
12-month period. The use of text messages enables us to
measure short-term sick leave (≤ 14 days) that is not cov-
ered by the MiDAS register. A 36-month follow-up of
sickness absenteeism based on register data is planned.
Primary outcome
Registered sick leave The primary outcome is the total
number of days of sick leave 18 months after baseline.
Data from MiDAS will be collected from baseline until
the 18-month follow-up and for the 24 months before
baseline. Information about the number of days on sick
leave, episodes of sick leave after RTW, and receipt of
disability pension will be collected for all participants.
Sickness benefit and disability pension will be analyzed
separately.
The total number of days of registered sick leave will
be calculated after 36 months in the same way as at the
18-month follow-up.
Secondary outcomes
Self-reported short-term sick leave, part-time registered
sick leave, psychological symptoms, work ability, impair-
ment of work performance, presenteeism, health-related
quality of life (HRQoL).
Self-reported sick leave and return to work Short--
term sick leave will be assessed by the question: ‘How
many days in the past four weeks have you been absent
from work because of illness? Answer with a number be-
tween 0 and 28 days’. Self-reported, short-term sick leave
has been shown to demonstrate acceptable reliability
[31]. The time from baseline until 1) partial RTW or 2)
full RTW (defined as working ordinary hours for an
uninterrupted period of at least four weeks) will be cal-
culated. The prevalence of no sick leave, partial and
full-time sick leave during the 12-month follow-up will
be calculated.
Part-time registered sick leave Part-time registered
sick leave will be calculated from baseline during the
18-month follow-up as registered part-time (25/50/75%
of full-time) sickness absenteeism.
Psychological symptoms Reduction of self-reported
anxiety and depression will be measured by the Hospital
Anxiety and Depression Scale, a well-established and
much used scale in primary health care with 14 items
used for the assessment of anxiety (7 items) and depres-
sion (7 items) [32]. The response format is a 4-point Likert
scale, ranging from 0 to 3, with higher scores indicating
anxiety and/or depression. Self-reported, stress-related
exhaustion disorder will be assessed by means of the
self-reported exhaustion scale (s-ED), a scale which has
demonstrated construct and predictive validity. The re-
sponse format is yes/no [33].
Work ability Work ability will be measured as im-
proved working ability and reduction in work-related
stress. The measure is self-reported work ability assessed
by three items from the Work Ability Index. The items
concern perceived work ability in relation to physical
and mental demands at work and the employee’s prog-
nosis of his/her work ability two years hence [34].
Sickness presenteeism and work performance Sick-
ness presenteeism will be measured by the single ques-
tion: ‘Did you, in the last six months, go to work even
though you felt that you really should have taken sick
leave because of your state of health?’ [35]. The response
format is a 4-point scale ranging from 0 (never) to 4 (more
than 5 times). This item has been extensively used in
previous research [35, 36]. In addition, two items about im-
pairment of work performance due to 1) health problems
(presenteeism) and 2) work-environment problems will be
assessed. The first has been developed and adapted from
the Work Productivity Impairment – General Health Ques-
tionnaire [37]; the second has been developed and tested
for validity and reliability in Sweden [38]. The response
format for both is 0 to 10, with higher scores indicating
that health problems or work-environment problems have
prevented the employee from working.
Health problems HRQoL will be assessed by the Euro-
QoL health state questionnaire (EQ-5D). The response
format is a 3-level scale, with higher levels indicating
severity [39]. We will use the subscale for insomnia from
the Karolinska Sleep Questionnaire, to assess sleeping
problems. The response format range from 0 (never) to
5 (always), higher scores indicate severity [40].
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Prognostic measures A variety of prognostic measures
for sick leave will be included in the study. At baseline,
participants’ personal characteristics (e.g. age, gender,
marital status, educational level), workplace characteristics
(e.g. sector, profession) and sick leave two years before in-
clusion will be collected from the LISA and MiDAS regis-
ters. In addition, questions covering all dimensions from
the demand-control-support model [41] will be included
as a prognostic variable. Psychological and social factors at
work and work-family balance will be assessed by items
from the General Nordic Questionnaire [42] which
focus on ongoing conflicts with the employer/superior, per-
ceived loss of control over work tasks, conflicts between
the employee’s values and how work is carried out and
work-family balance. Organizational factors at work will be
assessed by items from the Copenhagen Psychosocial Ques-
tionnaire [43] with focus on the emotional demands made
by the employee’s work. Finally, the employee’s self-efficacy
in RTW will be assessed as a prognostic factor [44].
Information about treatment (i.e. psychological coun-
seling, number of sessions, use of antidepressants) and
health care consumption will be collected from employees’
medical records and the Vega register from baseline until
the 18-month follow-up.
Process evaluation
As recommended by Moore GF, et al. [45], a process
evaluation will be conducted. The process evaluation
[46] will examine (1) the study’s fidelity, i.e. whether and
to what extent it is possible to implement the interven-
tion according to the protocol, (2) reach, dose delivered
and dose received, i.e. the relationship between the key
elements of the intervention and the effect outcome,
and (3) the study’s context, i.e. how the RCs, the persons
on sick leave, their employers, their physicians and other
stakeholders (e.g. occupational health service, social in-
surance agency officer) perceive the intervention and the
obstacles and enablers which influence the implementa-
tion. Process-evaluation data will be collected by means of
questionnaires, employees’ medical records and individual
interviews with RCs, employees and their employers.
Fidelity will be measured by a questionnaire contain-
ing questions about whether the intervention was deliv-
ered as planned. The RCs in the intervention group will
report overall adherence to the manual/fidelity to the
method for each employee during the study, after the
employee has participated in the problem-solving process.
Reach is measured for RCs and employees. The RCs par-
ticipation in the two-day training course will be assessed
by attendance and their satisfaction with the course. Eligi-
bility will be screened by medical records, while reach will
be assessed as those who are willing to participate in the
study. Dose delivered will be assessed by means of a ques-
tionnaire for the RCs which asks questions about the
frequency of face-to-face meetings with the employee,
number of telephone follow-ups and the frequency and
quality of the three-party meetings with the employer. Dose
received is defined as the whether or not the participants
receive the problem-solving intervention. Dose received
will be measured by how much of the intervention that the
participants received; number of sessions with the RC; how
much the participants were exposed to the different com-
ponents of the intervention. The content and fulfillment of
the recommended follow-ups with the employees will be
addressed. The RCs in the control group will receive a
check list which helps them to report the content in the
control condition.
Economic evaluation
A cost-utility analysis will be conducted to analyze
changes in HRQoL measured by EQ-5D and translated
using the Swedish experience-based value set [39] and
societal costs. Direct costs for health care will be esti-
mated based on administrative data from the Vega
register. Indirect costs will be estimated using the human
capital approach from sick leave (self-reported and regis-
tered in MiDAS) and self-reported presenteeism. All-cause
health care use will be collected from the Vega register
over 18 months after baseline. This register covers diagno-
ses, the reason for visits and measures taken for patients
visiting primary and specialized healthcare in the Västra
Götaland region of Sweden [47].
Moreover, a cost-effectiveness analysis will be con-
ducted to compare changes in days on sick leave to the
direct health care costs, including the costs for conduct-
ing the intervention, calculated based on time reported
by the RCs.
Evaluation of ethical issues
An ethical analysis will be performed focusing on central
ethical values and norms for the Swedish health care sys-
tem: patient autonomy and privacy, equality and fairness
as well as professional ethos and integrity. The ethical
analysis will analyse whether the changes brought about
through the intervention will emphasise or mitigate eth-
ical challenges in relation to this patient group. Data will
be collected through focus groups interviews with the dif-
ferent stakeholders: employees, employers, rehabilitation
coordinators, physicians responsible for sickness certifica-
tion, social insurance agency officers and representatives
of occupational health services. Interview guides based on
an ethics framework used in health-technology assessment
will be developed [48]. Focus group interviews will be
analysed using manifest content analysis.
Based on the results from the focus groups interview
and taking into considerations the actual changes implied
by the intervention, strategies for how to handle identified
ethical challenges or problems will be developed. The
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methodology of reflective equilibrium will be used, where
strategies are developed to be consistent with established
ethical values and norms within the Swedish health care
system, as found in the Swedish health care legislation and
in health care practice [49–51].
Randomization
The study has a two-armed cluster randomized design
and takes place at the level of RCs. The RCs are random-
ized into the intervention group or the control group
(CAU) by means of computer-generated random num-
bers. The randomization is stratified according to the
PCCs care-need index. This index includes variables such
as age, education, employment status, single household
and single parent for all persons belonging to each PCC.
The index is expected to have an impact on the results
and consequently a balance within the strata is required.
A RC covers between one and three PCCs. The RCs in
the Västra Götaland region have their own networks and
meetings four times a year. Because it is important to
avoid contamination, the RCs allocated to the interven-
tion arm are instructed to talk about the intervention
only with each other.
Blinding
This study has a cluster-randomization design, in which
the employees follow the RCs at the PCCs and are ran-
domized before they give informed consent. The em-
ployees in both the intervention and the control group
receive the same information about the study to equalize
employees’ expectations about their participation in the
study. The employees are blinded for the treatment allo-
cation since they receive no information about the other
group. The RCs are instructed not to tell employees that
the study consists of two groups, to ensure that the em-
ployees are not aware about the two conditions. The
RCs are not blinded for treatment allocation because the
RCs in the intervention arm will know that they will re-
ceive education and training. An independent statistician
will perform the analyses and will be blinded for partici-
pant allocation.
Data analysis
Statistical analyses adapted for cluster-randomized con-
trolled trials will be conducted. Linear and generalized
linear models will be used. Intention-to-treat analyses
and, if relevant, per-protocol analyses will be conducted.
Potential confounders will be adjusted for in the ana-
lyses, if they prove to be unevenly distributed and might
be expected to have an impact on the outcomes when
the intervention is compared with the control condition.
Possible interaction effects on the primary and second-
ary outcomes for (1) gender x treatment, and (2) number
of sessions with RC x treatment will be assessed. If they
are statistically significant, appropriate analyses will be
considered. Data collected from interviews and focus
groups will be analyzed by methods adapted for qualita-
tive data and normative analysis (cf. [48, 52, 53]).
Statistical power We estimate that the study population
needs to be 220 participants: 110 participants in the inter-
vention and the control group respectively. The partici-
pants will be obtained by sampling 10 clusters with 11
participants each in the intervention group and the same
number of clusters and participants in the control group.
With these numbers it will be possible to achieve around
80% power to detect a difference between the groups of at
least 20% of registered sickness absence 18 months after
baseline. The intra-cluster correlation was set to 0.010.
This sample size calculation is relevant for statistical ana-
lyses that take into account a correction factor for the
effect of a clustered design and use an alpha level of 0.05.
Discussion
The study is designed as a pragmatic, effectiveness trial
that will investigate whether employees on sick leave will
benefit from a problem-solving intervention delivered by
RCs in primary health care. Analyses will be performed
to examine whether the problem-solving intervention
has been more successful in reducing sick leave than
CAU. In a parallel process evaluation, the RCs’ adher-
ence to the protocol and how treatment fidelity, dose de-
livered and dose received might influence the sickness
absence outcome will be investigated. Furthermore, the
process evaluation will increase our understanding of
the obstacles to and facilitators of the intervention, con-
textual factors and the experience of taking part in the
intervention. The economic evaluation will examine the
intervention’s economic impact on society and the health
care system that is expected to deliver the intervention if
it is successful. In a health care system guided by and
founded on ethical values and norms, it will be essential
to relate to, and have strategies for how to handle identi-
fied ethical challenges. This knowledge will form the basis
for future implementation of the problem-solving inter-
vention in primary health care.
Methodological considerations
The cluster-randomization, in which the RCs are ran-
domized to intervention and control groups, reduces the
risk of contaminating the employees who participate in
the study. The RCs will only provide the problem-solving
intervention or CAU. Another strength of the study is that
participants will be selected by a project assistant who
screens medical records for eligible employees on sick
leave. The project assistant will have no previous know-
ledge about the participants or the randomization, thereby
reducing the risk of selection bias.
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In the Swedish social insurance system, the employer
usually pays for sick leave up to and including day 14.
The MiDAS register therefore contains sick leave data
from day 15 of sick leave. Since short-term sick leave
may predict future long-term sick leave, valuable informa-
tion about short-term sick leave will be collected from the
employees. However, with self-reported questionnaires
there is always a risk of recall bias and drop-out. The use
of text messages facilitates repeated measurements with
short recall periods, while the questionnaires are adminis-
tered at baseline and at 6 and 12-month follow-up. The 6
and 12-month follow-ups may increase the risk of recall
bias, but this risk has to be weighed against the frequency
of the questionnaires that the participants have to fill in.
The data collected in the process evaluation will be
analyzed before the primary and secondary outcomes in
the effectiveness evaluation are known to the research
group, to prevent biasing interpretations of the interven-
tion’s effectiveness. One of the strengths of the proposed
method for the economic evaluation will be its use of
comprehensive individual-level data collected for admin-
istrative purposes, on both direct and indirect costs. A
strength of the proposed methodology for ethical ana-
lysis is it context-sensitivity in relation to the Swedish
health care system and its inherent ethical values and
norms. However, ethical analysis is, on top of demands
for internal consistency, dependent upon being critically
examined and acknowledged as relevant by the stake-
holders. Hence, dialogue concerning this analysis is crucial.
Possible impact of results
Sick leave due to CMDs is a matter of national and
international concern, not only for the individuals them-
selves but also for their employers and society at large.
The costs of sick leave for society are high. Conse-
quently, finding interventions that reduce these costs as
well as the human suffering represents cost effectiveness
for society and employers and greater well-being for in-
dividuals. Moreover, previous economic evaluations of
the problem-solving intervention have shown ambiguous
results with regards to its cost/effect balance. Costs are
furthermore known to differ between countries, based
on e.g. the financing of the health care systems. Thus,
there is a need for more thorough examination of the
intervention’s economic impact. Improved work ability
and worker health will be beneficial for individuals, their
employers, enterprises, organizations and society at large.
The ethical analysis will identify ethical challenges and ob-
stacles but also ethical advantages with the intervention,
and thereby provide basis to assess how the intervention
relates to the value basis of the Swedish health care and
welfare system. In a health care system, where new inter-
ventions are constantly introduced, such analyses are es-
sential to understand how the intervention fits into these
value systems. If the intervention shows promising results
for RTW and work ability, there are good prospects for
being able to implement and disseminate it in the pri-
mary health care service, which may result in positive
effects for society at large (e.g. lower costs for sick leave
and rehabilitation).
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